界面新闻记者 |陈杨界面新闻编辑 |谢欣9月24日,凯因科技发布关于诉讼进展暨收到撤诉裁定的公告。公司和吉利德之间关于丙肝药索磷布韦的专利诉讼告一段落。具体而言,凯因科技称,近日收到最高法出具的(2023)最高法知民终2907号《民事裁定书》,法院裁定准许吉利德(上海)撤回上诉,一审判决自裁定书送达之日起发生法律效力。且该裁定为终审裁定。公司称,该诉讼进展不会对其日常生产经营、当期及未来的损益产生...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.